Clinical Outcomes After Durable Mitral Valve Repair for Ischemic Mitral Regurgitation
Yoshiki Sawa(Osaka Police Hospital), Takuji Kawamura(The University of Osaka), Kazuhiro Taniguchi(Hyogo Medical University), Köichi Toda(The University of Osaka), Tetsuhisa Kitamura(The University of Osaka), Shigeru Miyagawa(The University of Osaka), Sho Komukai(The University of Osaka), Yusuke Misumi(The University of Osaka), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Ai Kawamura(Max Planck Institute for Heart and Lung Research), Takayoshi Ueno(The University of Osaka), Daisuke Yoshioka(The University of Osaka), Toru Kuratani, Noriyuki Kashiyama(The University of Osaka)
Cited by 2
Related Papers
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Thoracic and cardiovascular surgeries in Japan during 2018
|General Thoracic and Cardiovascular Surgery|2020|123
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
|Circulation Journal|2021|115